Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patientsMacLean Hall, Shari Pilon‐Thomas|Journal for ImmunoTherapy of Cancer|2023Cited by 34